Answer
Whether Givlaari (givosiran sodium) passes into human breast milk is unknown; animal data show milk excretion, infant risk cannot be excluded, and stopping breastfeeding or stopping/avoiding treatment must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- GivlaariAlnylam UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked